The global biomaterials market was valued at USD 178.79 billion in 2023 and is projected to reach USD 639.38 billion by 2032, growing at a CAGR of 15.21% from 2024 to 2032.
The market is driven by factors such as the aging population, increasing incidence of cardiovascular and orthopedic conditions, advancements in medical technology, and rising public awareness of implanted devices. Government investment in biomaterials research and development and growing consumer awareness of the benefits of biomaterials-based products also contribute to market expansion. However, the high cost of biomaterial implants and compatibility issues may hinder growth. Emerging technologies like hydrogen scaffolding and decellularized dermal matrices for grafting, along with new products in plastic surgery, wound healing, and neurology, are expected to offer lucrative opportunities for market growth.
Market Dynamics
Drivers:
- Increased Government Engagement in Developing Novel Biomaterials
Government and academic investments, funding, and grants support the development of innovative biomaterials. - Expansion of the Healthcare Industry in Developing Nations
Emerging markets are expected to see significant growth due to factors such as a growing patient population, increased use of implanted devices, rising disposable incomes, improved healthcare infrastructure, and less stringent regulatory environments. The BRICS countries (Brazil, Russia, India, China, and South Africa) are projected to account for one-third of global healthcare spending by 2023. The increasing geriatric population, demand for surgical procedures, and incidence of target diseases in these regions are anticipated to create new growth opportunities for biomaterials market participants.
Market Concentration & Characteristics
The biomaterials market is highly innovative, driven by advancements in bioengineering, nanotechnology, and regenerative medicine. These innovations lead to the development of biocompatible and bio-functional materials that enhance tissue regeneration and medical device performance. Major players like Medtronic plc, Evonik Industries AG, and Dentsply Sirona engage in mergers and acquisitions to expand their geographic reach. Regulatory frameworks ensure product safety and efficacy, driving industry compliance.
Biologically derived materials, such as plant-based polymers and tissue-engineered constructs, offer potential substitutes to traditional synthetic options. Research into alternative sources and sustainable biomaterials is driving the exploration of eco-friendly alternatives.
Product Insights
The metallic segment held the largest revenue share of over 40.0% in 2023 due to its mechanical properties, biocompatibility, and corrosion resistance. Metals are widely used for manufacturing load-bearing implants, such as orthopedic devices. The natural segment is expected to grow significantly due to its biodegradability, biocompatibility, and ability to facilitate cell adhesion, proliferation, and differentiation.
Application Insights
The orthopedic segment accounted for the largest revenue share in 2023, driven by the high load-bearing capacity of metallic biomaterials. Advances in orthopedic implants, such as DiFusion Inc.’s Xiphos-ZF spinal interbody device, are expected to drive growth. The plastic surgery segment is estimated to register the fastest CAGR due to increasing demand for cosmetic procedures and reconstructive surgeries, as well as advancements in biomaterial technology.
Regional Insights
North America: Dominated the market in 2023, with initiatives from organizations like the National Science Foundation and the National Institute of Standards and Technology increasing biomaterial adoption. The presence of major market players and favorable government policies contribute to the region’s market share.
Europe: Expected to grow significantly due to investments and innovations by major players, established infrastructure, and supportive government regulations. The high prevalence of cardiovascular diseases in the UK and a strong biomaterials market in Germany and France contribute to regional growth.
Asia Pacific: Expected to grow at the fastest CAGR, driven by strategic initiatives, advanced healthcare infrastructure, substantial R&D initiatives, and a rapidly aging population in countries like Japan and China.
Middle East & Africa: Growth is driven by increasing scientific awareness and adoption of biomaterial technologies, high prevalence of chronic diseases, and support from initiatives like the Biomanufacturing Innovation Centre and the Technology Innovation Agency in South Africa.
Recent Developments
- March 2023: Invibio Biomaterial Solutions launched the Peek-Optima Am filament for 3D-printed medical devices.
- January 2023: Zimmer Biomet Holdings, Inc. announced plans to acquire Embody, Inc. for up to USD 275 million, strengthening its sports medicine portfolio.
- October 2023: Evonik introduced the first carbon-fiber-reinforced PEEK filaments for 3D-printed medical implants, advancing patient-specific medical treatments.
Key Market Players and Competitive Landscape
The Major companies that contributed to the market expansion are BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany).
This report categorizes the biomaterials market as follows,
Biomaterials Market by Product Outlook (Revenue, USD Million, 2017 – 2030):
- Metallic
- Natural
- Ceramics
- Polymers
Biomaterials Market by Application Outlook (Revenue, USD Million, 2017 – 2030):
- Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Vascular Grafts
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
- Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Others
- Orthopedic
- Joint Replacement Biomaterials
- Orthobiologics
- Bioresorbable Tissue Fixation Products
- Viscosupplementation
- Spine Biomaterials
- Others
- Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
- Tissue Engineering
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold for CNS Repair
- Cortical Neural Prosthetics
- Others
- Others
Biomaterials Market by Regional Outlook (Revenue, USD Million, 2017 – 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
| Biomaterials Market Report Scope |
| Report Attribute | Details |
| Market Size Value in 2023 | USD 178.79 billion |
| Revenue Forecast in 2032 | USD 639.38 billion |
| Growth Rate | CAGR of 15.21 % From 2024 to 2032 |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 – 2023 |
| Forecast Years | 2024 – 2032 |
| Quantitative Units | Revenue in USD million and CAGR from 2024 to 2032 |
| Report Coverage | Revenue forecast, company ranking, Trends
competitive landscape, and growth factors |
| Segments Covered | Product, Application, and Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico and Others |
| Key Companies Profiled | BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany) |
Table of Content
Biomaterials Market Size, Share, Growth, and Forecast Report
1. Introduction
1.1. Report Description
1.1.1. Aim of the Report
1.1.2. Prospective Audience
1.1.3. Unique Selling Prepositions and Key Takeaways from the Report
1.2. Scope of the Research Study
1.3. Approach/Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Expert Panel Review
1.3.4. Market Data Breakdown and Data Triangulation
1.3.5. Research Approach for Market Size Estimation
1.3.5.1. Top-Down Approach
1.3.5.2. Bottom-Up Approach
1.3.6. Key Assumptions
1.4. Market Segmentation
1.4.1. Product
1.4.2. Application
2. Biomaterials Market Overview
2.1. Introduction
2.2. Analysis by Product, 2017-2030 (US$ Billion)
2.3. Analysis by Application, 2017-2030 (US$ Billion)
2.4. Market Analysis by Region, 2017-2030 (US$ Billion)
3. Biomaterials Market Dynamics
3.1. Introduction
3.2. Growth Drivers
3.3. Growth Restraints
3.4. Growth Opportunities
3.5. Porter’s Five Forces Analysis
3.5.1. Threat of New Entrants
3.5.2. Bargaining Power of Buyers/Consumers
3.5.3. Bargaining Power of Suppliers
3.5.4. Threat of Substitute Products
3.5.5. Intensity of Competitive Rivalry
3.6. Attractiveness Analysis
3.6.1. Product
3.6.2. Application
3.6.3. Region
3.7. Value Chain Analysis
4. Biomaterials Market Competition Analysis
4.1. Biomaterials Market Share Analysis by Company, 2019 – 2021
4.1.1. Top 3 Players, 2019 – 2021
4.1.2. Top 6 Players, 2019 – 2021
4.2. Strategic Initiatives
4.2.1. New Products Launch
4.2.2. Mergers/Acquisitions
4.2.3. Agreement and Collaborations
4.2.4. Partnerships, Joint Ventures, Expansion, and Distribution
5. Global Biomaterials Market Analysis by Product and Application, 2017-2030 (US$ Billion)
5.1. Product
5.1.1. Global Biomaterials Market Share, by Product, 2021 and 2030
5.1.2. Global Biomaterials Market Revenue, by Product, 2017-2030 (US$ Billion)
5.1.3. By Metallic Market Analysis 2017-2030 (US$ Billion)
5.1.4. By Natural Market Analysis 2017-2030 (US$ Billion)
5.1.5. By Ceramics Market Analysis 2017-2030 (US$ Billion)
5.1.6. By Polymers Market Analysis 2017-2030 (US$ Billion)
5.2. Application
5.2.1. Market Share, by Application, 2021 and 2030
5.2.2. Market Revenue, by Application, 2017-2030 (US$ Billion)
5.2.3. By Cardiovascular Market Analysis 2017-2030 (US$ Billion)
5.2.4. By Ophthalmology Market Analysis 2017-2030 (US$ Billion)
5.2.5. By Dental Market Analysis 2017-2030 (US$ Billion)
5.2.6. By Orthopedic Market Analysis 2017-2030 (US$ Billion)
5.2.7. By Wound Healing Market Analysis 2017-2030 (US$ Billion)
5.2.8. By Tissue Engineering Market Analysis 2017-2030 (US$ Billion)
5.2.9. By Plastic Surgery Market Analysis 2017-2030 (US$ Billion)
5.2.10. By Neurology Market Analysis 2017-2030 (US$ Billion)
5.2.11. By Others Application Market Analysis 2017-2030 (US$ Billion)
6. Global Biomaterials Market Product Analysis by Region, 2017-2030 (US$ Billion)
6.1. Metallic Market Analysis 2017-2030 (US$ Billion)
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East & Africa
6.2. Natural Market Analysis 2017-2030 (US$ Billion)
6.3. Ceramics Market Analysis 2017-2030 (US$ Billion)
6.4. Polymers Market Analysis 2017-2030 (US$ Billion)
7. Global Biomaterials Market Application Analysis by Region, 2017-2030 (US$ Billion)
7.1. Cardiovascular Market Analysis 2017-2030 (US$ Billion)
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Latin America
7.1.5. Middle East & Africa
7.2. Ophthalmology Market Analysis 2017-2030 (US$ Billion)
7.3. Dental Market Analysis 2017-2030 (US$ Billion)
7.4. Orthopedic Market Analysis 2017-2030 (US$ Billion)
7.5. Wound Healing
7.6. Tissue Engineering
7.7. Plastic Surgery
7.8. Neurology
7.9. Others
8. Biomaterials Market Analysis by Geography, 2017-2030 (US$ Billion)
8.1. North America Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.1.1. U.S. Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.1.1.1. Product
8.1.1.2. Application
8.1.2. Canada Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.1.3. Mexico Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2. Europe Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.1. UK Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.1.1. Product
8.2.1.2. Application
8.2.2. France Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.3. Germany Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.4. Spain Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.5. Russia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.6. Italy Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.2.7. Rest of Europe Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3. Asia Pacific Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.1. China Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.1.1. Product
8.3.1.2. Application
8.3.2. Japan Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.3. South Korea Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.4. India Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.5. Australia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.6. Southeast Asia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.7. Taiwan Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.3.8. Rest of Asia Pacific Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4. Latin America Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4.1. Brazil Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4.1.1. Product
8.4.1.2. Application
8.4.2. Argentina Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.4.3. Rest of Latin America Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5. Middle East Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.1. Israel Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.1.1. Product
8.5.1.2. Application
8.5.2. Turkey Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.3. Saudi Arabia Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.4. UAE Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.5.5. Rest of Middle East Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6. Africa Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6.1. Egypt Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6.1.1. Product
8.6.1.2. Application
8.6.2. South Africa Biomaterials Market Analysis 2017-2030 (US$ Billion)
8.6.3. Rest of Africa Biomaterials Market Analysis 2017-2030 (US$ Billion)
9. Company Profiles
9.1. BASF SE (Germany)
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Covestro AG (Germany)
9.3. Celanese Corporation (US)
9.4. Corbion (Netherlands)
9.5. Royal DSM (Netherlands)
9.6. Evonik Industries (Germany)
9.7. Carpenter Technology Corporation (US)
9.8. Berkeley Advanced Biomaterials (US)
9.9. Cam Bioceramics B.V. (Netherlands)
9.10. CoorsTek Inc. (US)
9.11. CeramTec (Germany)
9.12. Gelita AG (Germany)
10. COVID-19 Impact Analysis
10.1. Global Biomaterials Market, 2020 – 2030, Pre-V/S Post COVID 19
10.2. Estimated Impact of The Coronavirus (Covid-19) Epidemic on the Biomaterials Market Size In 2022, By Scenario
10.3. Impact on Supply Chain and Production in Biomaterials Market
10.4. Impact on Import and Export
11. Import-Export Analysis
11.1. North America Biomaterials Import-Export, 2017 – 2021
11.2. Europe Biomaterials Import-Export, 2017 – 2021
11.3. Asia Pacific Biomaterials Import-Export, 2017 – 2021
11.4. Latin America Biomaterials Import-Export, 2017 – 2021
11.5. Middle East America Biomaterials Import-Export, 2017 – 2021
11.6. Africa Biomaterials Import-Export, 2017 – 2021
12. Biomaterials Marketing Channel Analysis
12.1. Marketing Channel
12.1.1. Direct Marketing
12.1.2. Indirect Marketing
12.1.3. Development Trend
12.2. Market Positioning
13. Biomaterials Manufacturing Cost Analysis
13.1. Key Raw Materials
13.2. Key Raw Material Suppliers
13.3. Market Concentration Rate
13.4. Manufacturing Cost Structure
13.5. Process Analysis
14. Conclusion
Biomaterials Market by Product Outlook (Revenue, USD Million, 2017 – 2030):
- Metallic
- Natural
- Ceramics
- Polymers
Biomaterials Market by Application Outlook (Revenue, USD Million, 2017 – 2030):
- Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Vascular Grafts
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
- Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Others
- Orthopedic
- Joint Replacement Biomaterials
- Orthobiologics
- Bioresorbable Tissue Fixation Products
- Viscosupplementation
- Spine Biomaterials
- Others
- Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
- Tissue Engineering
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold for CNS Repair
- Cortical Neural Prosthetics
- Others
